LGND
Ligand Pharmaceuticals Incorporated
NASDAQ · USHealthcareBiotechnology
$301.63-0.58%
Price as of Jul 20, 2026
LGND ownership
Ligand Pharmaceuticals Incorporated ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
38
Net (3m)
-$9.0M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +30.9%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 900 | $315.78 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Option | 5,000 | $52.27 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 1,081 | $312.28 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 100 | $314.58 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 700 | $313.46 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 396 | $308.99 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 1,119 | $311.72 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 600 | $317.15 |
| Jul 6, 2026 | Reardon Andrewofficer: CLO & Secretary | Sell | 104 | $310.20 |
| Jun 18, 2026 | Sabba Stephen Ldirector | Sell | 2,145 | $254.00 |
| Jun 18, 2026 | Sabba Stephen Ldirector | Option | 2,145 | $66.13 |
| Jun 15, 2026 | Haas Jasondirector | Option | 3,000 | $51.56 |
| Jun 15, 2026 | Haas Jasondirector | Sell | 3,461 | $256.08 |
| Jun 15, 2026 | Haas Jasondirector | Option | 1,000 | $51.56 |
| Jun 15, 2026 | Haas Jasondirector | Sell | 3,000 | $255.01 |
| Jun 12, 2026 | Aryeh Jasondirector | Sell | 4,500 | $250.00 |
| Jun 12, 2026 | Aryeh Jasondirector | Sell | 500 | $250.00 |
| Jun 12, 2026 | LAMATTINA JOHN Ldirector | Sell | 3,405 | $251.62 |
| Jun 12, 2026 | Aryeh Jasondirector | Grant | 2,938 | $237.00 |
| Jun 12, 2026 | Aryeh Jasondirector | Grant | 836 | — |
| Jun 12, 2026 | LAMATTINA JOHN Ldirector | Sell | 257 | $247.22 |
| Jun 12, 2026 | LAMATTINA JOHN Ldirector | Sell | 232 | $248.11 |
| Jun 12, 2026 | LAMATTINA JOHN Ldirector | Sell | 697 | $249.53 |
| Jun 9, 2026 | Sabba Stephen Ldirector | Grant | 836 | — |
| Jun 9, 2026 | Sabba Stephen Ldirector | Grant | 2,938 | $237.00 |
| Jun 9, 2026 | KOZARICH JOHN Wdirector | Grant | 836 | — |
| Jun 9, 2026 | Gray Nancy Ryandirector | Grant | 2,938 | $237.00 |
| Jun 9, 2026 | LAMATTINA JOHN Ldirector | Grant | 836 | — |
| Jun 9, 2026 | KOZARICH JOHN Wdirector | Grant | 2,938 | $237.00 |
| Jun 9, 2026 | LAMATTINA JOHN Ldirector | Grant | 2,938 | $237.00 |
Source: LGND SEC Form 4 filings, latest Jul 6, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their LGND positions over the last 6 months (SEC Form 13F).
Increased
253
New positions
130
Reduced
229
Sold out
73
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 3.0M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 2.9M | Feb 12, 2026 |
| VANGUARD GROUP INC | Reduced | 2.1M | Jan 29, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 1.1M | May 8, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 1.0M | May 18, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 995K | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 848K | May 15, 2026 |
| INVESCO LTD. | Increased | 824K | May 12, 2026 |
| STATE STREET CORP | Increased | 779K | May 15, 2026 |
| STATE STREET CORP | Increased | 751K | Feb 13, 2026 |
| CONGRESS ASSET MANAGEMENT CO | Increased | 660K | Jul 7, 2026 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | New Position | 644K | Feb 17, 2026 |
| FMR LLC | Increased | 596K | May 15, 2026 |
| FMR LLC | Increased | 579K | Feb 17, 2026 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | Reduced | 573K | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.